NCT06816329

Brief Summary

Stress and a parental history of major depressive disorder (MDD) are among the strongest risk factors for future development of MDD. Studies have shown that having a parental history of MDD may be associated with behavioral, psychophysiological, and hormonal responses to stress that are associated with poorer stress coping. . Adolescence is a vulnerable developmental window linked to increased MDD risk, especially for females, as rates of MDD surge relative to males. Despite the central role of stress in MDD onset, little is known about the brain mechanisms underlying stress responses in susceptible female adolescents at high familial risk for MDD. Also, it is unclear how stress-related brain network alterations may relate to "real-world" maladaptive stress responses and whether these stress-related brain network changes are predictive of future depression onset. We will fulfill these research gaps by combining neuroimaging with intensive longitudinal tracking of depressive symptomology as well as behavioral and physiological responses to "real world" stress using smartphone and smartwatch technology. Elucidating these neural mechanisms may aid in the discovery of MDD biomarkers that could identify youth at greatest risk for future MDD development and lead to earlier intervention efforts.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable major-depressive-disorder

Timeline
47mo left

Started Oct 2025

Longer than P75 for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Oct 2025Mar 2030

First Submitted

Initial submission to the registry

January 28, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

October 15, 2025

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2030

Last Updated

October 23, 2025

Status Verified

October 1, 2025

Enrollment Period

4.5 years

First QC Date

January 28, 2025

Last Update Submit

October 22, 2025

Conditions

Keywords

stressdepressionadolescentsneuroimagingfamilial risk

Outcome Measures

Primary Outcomes (3)

  • Time Spent in Default Mode-Frontoparietal Network Coactivation Pattern (CAP)

    Time Spent in Default Mode-Frontoparietal Network Coactivation Pattern (CAP). An fMRI variable. (the number of volumes spent in this CAP).

    Throughout a 1.75 hour MRI scan collected during the middle of a 3.5 hour 2nd study session

  • Persistence in default mode network-frontoparietal network co-activation pattern

    Persistence in default mode network-frontoparietal network CAP. An fMRI measure. (the average number of consecutive volumes spent in this CAP)

    Throughout a 1.75 hour MRI scan collected during the middle of a 3.5 hour 2nd study session

  • Depressive Symptoms

    The total score on the Mood and Feelings Questionnaire \[Min Score: 0, Max Score: 66, higher scores mean more severe depressive symptoms)

    Collected at baseline, the beginning of a 1.75 hour MRI, and at 6-, 12-, and 18-month follow-ups

Secondary Outcomes (5)

  • Cortisol

    Collected throughout a 3.5 hour second study session that involves a 1.75 hour MRI conducted at the middle of the session

  • Stress Ratings

    Collected during a two-week period immediately after the 2nd study session (i.e., the MRI session), and then in the two-weeks immediately after the 6-, 12-, and 18-month follow-up sessions, respectively

  • Average heart rate (beats per minute)

    Collected during a two-week period immediately after the 2nd study session (i.e., the MRI session), and then in the two-weeks immediately after the 6-, 12-, and 18-month follow-up sessions, respectively

  • heart rate variability

    Collected during a two-week period immediately after the 2nd study session (i.e., the MRI session), and then in the two-weeks immediately after the 6-, 12-, and 18-month follow-up sessions, respectively

  • Sleep duration

    Collected during a two-week period immediately after the 2nd study session (i.e., the MRI session), and then in the two-weeks immediately after the 6-, 12-, and 18-month follow-up sessions, respectively

Study Arms (1)

Computer Task Manipulation

EXPERIMENTAL

Participants will complete computer tasks while undergoing an fMRI brain scan.

Behavioral: Computer Task Manipulation

Interventions

Participants will complete computer tasks.

Computer Task Manipulation

Eligibility Criteria

Age13 Years - 15 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female.
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Female sex assigned at birth
  • Ages 13-15
  • English as first language or English Fluency
  • Right-handed
  • Have a personal cell phone to complete the ecological momentary assessments
  • Ability to give signed, informed consent/assent either written or electronic (via RedCap eConsent)
  • Normal or corrected to normal vision and hearing
  • A biological parent meeting DSM-5 criteria for at least one past/current major depressive episode

You may not qualify if:

  • Presence of any contraindication for MRI:
  • Cardiac pacemakers
  • Metal clips on blood vessels (also called stents)
  • Artificial heart valve, artificial arms, hands, legs, etc.
  • Brain stimulator devices
  • Implanted drug pumps
  • Ear or eye implants
  • Known metal fragments in eyes
  • Exposure to metal filings or shrapnel (sheet metal workers, welders, and others)
  • Other metallic surgical hardware in vital area
  • Certain tattoos with metallic ink
  • Certain intrauterine devices (IUDs) containing metal
  • Any other metallic objects that are deemed a contraindication to MRI that cannot be removed
  • Certain transdermal (skin) patches such as:
  • NicoDerm (nicotine for tobacco dependence) Transderm Scop (scopolamine for motion sickness) Ortho Evra (birth control)
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McLean Hospital

Belmont, Massachusetts, 02478, United States

RECRUITING

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Emily Belleau, Ph.D.

    Mclean Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Case-Control Design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 10, 2025

Study Start

October 15, 2025

Primary Completion (Estimated)

March 31, 2030

Study Completion (Estimated)

March 31, 2030

Last Updated

October 23, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Demographic, clinical, neuroimaging, psychophysiological, ecological momentary assessment, and smartwatch data will be preserved to enable sharing via NDA data of sufficient quality to validate and replicate research findings described in the Aims. NIMH requires data measured from human subjects to be shared using the NDA. All data will be deposited to NDA starting 12 months after the award begins and will be deposited every six months thereafter following the usual NDA data submission dates. Data will be findable for the research community through the NDA Collection that will be established when this application is funded. For all publications, an NDA study will be created. Each of those studies are assigned a digital object identifier (DOI). This data DOI will be referenced in the publication to allow the research community easy access to the exact data used in the publication. The research community will have access to data when the award ends.

Shared Documents
ANALYTIC CODE
Time Frame
The research community will have access to data when the award ends. NDA will make decisions about how long to preserve the data, but that data archive has not deleted any deposited data up to now.
Access Criteria
To request access of the data, researchers will use the standard processes at NDA, and the NDA Data Access Committee will decide which requests to grant. The standard NDA data access process allows access for one year and is renewable

Locations